WallStreetZenWallStreetZen

NASDAQ: CCCC
C4 Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CCCC

Based on 1 analyst offering 12 month price targets for C4 Therapeutics Inc

Min Forecast
$12.00+241.88%
Avg Forecast
$12.00+241.88%
Max Forecast
$12.00+241.88%

Should I buy or sell CCCC stock?

Based on 1 analyst offering ratings for C4 Therapeutics Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CCCC's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates CCCC as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their CCCC stock forecasts and price targets.

CCCC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-06-01

1 of 1

Forecast return on equity

Is CCCC forecast to generate an efficient return?

Company
36.03%
Industry
20.5%
Market
167.71%
CCCC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CCCC forecast to generate an efficient return on assets?

Company
24.79%
Industry
23.66%
CCCC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CCCC earnings per share forecast

What is CCCC's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
-$0.89
Avg 2 year Forecast
-$0.94
Avg 3 year Forecast
-$1.34

CCCC revenue forecast

What is CCCC's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$21.9M-37.63%
Avg 2 year Forecast
$22.6M-35.55%
Avg 3 year Forecast
$18.3M-47.82%
CCCC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CCCC revenue growth forecast

How is CCCC forecast to perform vs Biotechnology companies and vs the US market?

Company
-18.14%
Industry
32.79%
Market
13.22%
CCCC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CCCC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CCCC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CCCC$3.51$12.00+241.88%Buy
AVIR$5.31$7.00+31.83%Hold
BNTC$12.19$20.50+68.17%Buy
ARCT$14.73$24.50+66.33%Strong Buy
EDIT$2.70$4.00+48.15%Strong Buy
View Top Biotech Stocks

C4 Therapeutics Stock Forecast FAQ

Is C4 Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CCCC) stock is to Buy CCCC stock.

Out of 1 analyst, 0 (0%) are recommending CCCC as a Strong Buy, 1 (100%) are recommending CCCC as a Buy, 0 (0%) are recommending CCCC as a Hold, 0 (0%) are recommending CCCC as a Sell, and 0 (0%) are recommending CCCC as a Strong Sell.

If you're new to stock investing, here's how to buy C4 Therapeutics stock.

What is CCCC's earnings growth forecast for 2026-2028?

(NASDAQ: CCCC) C4 Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.23%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.8%.

C4 Therapeutics's earnings in 2026 is -$101,416,000.On average, 9 Wall Street analysts forecast CCCC's earnings for 2026 to be -$109,258,623, with the lowest CCCC earnings forecast at -$120,564,633, and the highest CCCC earnings forecast at -$101,274,292. On average, 9 Wall Street analysts forecast CCCC's earnings for 2027 to be -$115,742,048, with the lowest CCCC earnings forecast at -$132,621,097, and the highest CCCC earnings forecast at -$86,548,183.

In 2028, CCCC is forecast to generate -$165,333,480 in earnings, with the lowest earnings forecast at -$198,931,645 and the highest earnings forecast at -$113,675,226.

What is CCCC's revenue growth forecast for 2026-2028?

(NASDAQ: CCCC) C4 Therapeutics's forecast annual revenue growth rate of -18.14% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 32.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.22%.

C4 Therapeutics's revenue in 2026 is $35,039,000.On average, 8 Wall Street analysts forecast CCCC's revenue for 2026 to be $2,688,591,322, with the lowest CCCC revenue forecast at $1,567,340,233, and the highest CCCC revenue forecast at $3,836,538,866. On average, 8 Wall Street analysts forecast CCCC's revenue for 2027 to be $2,778,276,646, with the lowest CCCC revenue forecast at $1,567,340,233, and the highest CCCC revenue forecast at $3,836,538,866.

In 2028, CCCC is forecast to generate $2,249,391,587 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $3,836,538,866.

What is CCCC's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: CCCC) forecast ROA is 24.79%, which is higher than the forecast US Biotechnology industry average of 23.66%.

What is CCCC's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CCCC price target, the average CCCC price target is $12.00, with the highest CCCC stock price forecast at $12.00 and the lowest CCCC stock price forecast at $12.00.

The Wall Street analyst predicted that C4 Therapeutics's share price could reach $12.00 by Jun 1, 2027. The average C4 Therapeutics stock price prediction forecasts a potential upside of 241.88% from the current CCCC share price of $3.51.

What is CCCC's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: CCCC) C4 Therapeutics's current Earnings Per Share (EPS) is -$0.91. On average, analysts forecast that CCCC's EPS will be -$0.89 for 2026, with the lowest EPS forecast at -$0.98, and the highest EPS forecast at -$0.82. On average, analysts forecast that CCCC's EPS will be -$0.94 for 2027, with the lowest EPS forecast at -$1.08, and the highest EPS forecast at -$0.70. In 2028, CCCC's EPS is forecast to hit -$1.34 (min: -$1.62, max: -$0.92).

What is CCCC's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: CCCC) forecast ROE is 36.03%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.